Booz Allen Hamilton vs Equifax
Add, change or remove companies; up to four.
KIRA’s take AI analyst
I put Booz Allen Hamilton and Equifax side by side, using each one’s latest annual report. Here is what stands out:
- Booz Allen Hamilton is the larger business, with $11.2B of revenue in fiscal 2026 against $6.1B for Equifax, about 1.8 times as much.
- Equifax grew revenue faster (6.9%, against −6.4%).
- Equifax kept more of each dollar of sales as operating profit (18.0% operating margin, against 9.2%).
- Equifax turned more of its sales into free cash flow (18.7% FCF margin, against 8.5%).
- Booz Allen Hamilton earned a higher return on the capital invested in it (24.2%, against 8.5%).
- Investors pay more for each dollar of Equifax’s earnings: a P/E of 28.9x against 12.9x for Booz Allen Hamilton.
Who comes out ahead
Of the 10 measures where higher (or lower) is clearly better, how many each company leads.
Booz Allen Hamilton
BAH
4/10
Return on capitalReturn on equityNet debt / EBITDAShare count change
Equifax
EFX
6/10
Revenue growth5-year growthOperating marginNet marginFCF marginPiotroski F-score
Side by side
Best in the row
| Latest fiscal year | BAH FY26 | EFX FY25 |
|---|---|---|
| Size | ||
| Market cap | $10.0B | $21.1B |
| Revenue | $11.2B | $6.1B |
| Free cash flow | $951M | $1.1B |
| Net income | $851M | $660M |
| Growth | ||
| Revenue growth | −6.4% | 6.9% |
| 5-year growth | 7.4% | 8.0% |
| Share count change | −4.6% | −0.6% |
| Profitability | ||
| Gross margin | 52.7% | — |
| Operating margin | 9.2% | 18.0% |
| Net margin | 7.6% | 10.9% |
| FCF margin | 8.5% | 18.7% |
| Return on capital | 24.2% | 8.5% |
| Return on equity | 80.7% | 14.1% |
| Balance sheet | ||
| Net debt | $3.2B | $4.9B |
| Net debt / EBITDA | 2.7x | 2.7x |
| Dividends and buybacks | $874M | $1.2B |
| Valuation & quality | ||
| P/E | 12.9x | 28.9x |
| Piotroski F-score | 5 | 6 |
Ten years
Revenue
Operating margin
Free cash flow
Return on capital
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.